Basis: Current FMP quote-based enterprise value / four-quarter operating income plus matched D&A. Source: stored company filings and market data; unavailable inputs remain N/A.

The EV/EBITDA ratio is N/A as of 2026-10-06T16:28:19.953Z.

Stored calculation inputs

Calculation as of: 2026-10-06T16:28:19.953Z.

Quote observation: 2026-10-06T16:24:27.000Z. Amounts in USD. The price header may show a later quote.

Quote market capitalization: 63,777,806
Total debt · period ending 2026-06-30: 28,743,000
Cash · period ending 2026-06-30: 24,883,000
TTM operating EBITDA · period ending 2026-06-30: -96,215,000

FMP input reference: e1640542559587d997c0d8eaeaaf8c892bebef217736e9d4e66575bab6404537

EV/Sales|P/E Ratio|EBITDA|All Metrics

PLRX EV/EBITDA Ratio Metrics

EV/EBITDA RATIO

N/A

EV/EBITDA RATIO AVG TTM

N/A

EV/EBITDA RATIO AVG 3Y

N/A

EV/EBITDA RATIO AVG 5Y

N/A

EV/EBITDA RATIO AVG 10Y

N/A

EV/EBITDA RATIO AVG 15Y

N/A

EV/EBITDA RATIO AVG 20Y

N/A

CURRENT VS TTM AVG

N/A

CURRENT VS 3Y AVG

N/A

CURRENT VS 5Y AVG

N/A

CURRENT VS 10Y AVG

N/A

CURRENT VS 15Y AVG

N/A

CURRENT VS 20Y AVG

N/A

PLRX Competitors' EV/EBITDA Ratio

PLRX

Pliant Therapeutics, Inc.

Current

Market Cap

$63.78M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ALPS

Alps Group Inc

vs PLRX

Market Cap

$64.06M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

INCR

InterCure Ltd.

vs PLRX

Market Cap

$63.14M

EV/EBITDA Ratio

N/A

TTM Avg

7.83x

3Y Avg

18.88x

5Y Avg

17.80x

GOSS

Gossamer Bio, Inc.

vs PLRX

Market Cap

$64.83M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

HRTX

Heron Therapeutics, Inc.

vs PLRX

Market Cap

$64.85M

EV/EBITDA Ratio

N/A

TTM Avg

250.18x

3Y Avg

250.18x

5Y Avg

250.18x

CING

Cingulate Inc.

vs PLRX

Market Cap

$65.86M

EV/EBITDA Ratio

0.22x

TTM Avg

0.03x

3Y Avg

0.03x

5Y Avg

0.03x

RNXT

RenovoRx, Inc.

vs PLRX

Market Cap

$66.23M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

KLRS

Kalaris Therapeutics Inc

vs PLRX

Market Cap

$61.16M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

CNTB

Connect Biopharma Holdings Limited

vs PLRX

Market Cap

$61.04M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ACET

Adicet Bio, Inc.

vs PLRX

Market Cap

$60.86M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	EV/EBITDA RATIO	TTM	3Y	5Y
Pliant Therapeutics, Inc. (PLRX)	$63.78M	N/A	N/A	N/A	N/A
Alps Group Inc (ALPS)vs ›	$64.06M	N/A	N/A	N/A	N/A
InterCure Ltd. (INCR)vs ›	$63.14M	N/A	7.83x	18.88x	17.80x
Gossamer Bio, Inc. (GOSS)vs ›	$64.83M	N/A	N/A	N/A	N/A
Heron Therapeutics, Inc. (HRTX)vs ›	$64.85M	N/A	250.18x	250.18x	250.18x
Cingulate Inc. (CING)vs ›	$65.86M	0.22x	0.03x	0.03x	0.03x
RenovoRx, Inc. (RNXT)vs ›	$66.23M	N/A	N/A	N/A	N/A
Kalaris Therapeutics Inc (KLRS)vs ›	$61.16M	N/A	N/A	N/A	N/A
Connect Biopharma Holdings Limited (CNTB)vs ›	$61.04M	N/A	N/A	N/A	N/A
Adicet Bio, Inc. (ACET)vs ›	$60.86M	N/A	N/A	N/A	N/A

EV/EBITDA Ratio Formula & Definition

EV/EBITDA = Enterprise Value / EBITDA (TTM)

Enterprise value to EBITDA is a capital-structure-neutral valuation multiple, useful for comparing companies with different debt levels and tax rates.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

PLRX EV/EBITDA Ratio History

DATE	EV/EBITDA RATIO
2021-03-16	62.83x
2021-03-15	62.37x
2021-03-12	62.08x
2021-03-11	62.41x
2021-03-10	62.24x
2021-03-09	62.19x
2021-03-08	55.78x
2021-03-05	50.95x
2021-03-04	52.02x
2021-03-03	58.58x
2021-03-02	59.91x
2021-03-01	57.68x
2021-02-26	53.63x
2021-02-25	64.94x
2021-02-24	65.49x
2021-02-23	55.40x
2021-02-22	56.81x
2021-02-19	53.75x
2021-02-18	49.01x
2021-02-17	51.73x
2021-02-16	53.31x
2021-02-12	50.62x
2021-02-11	48.16x
2021-02-10	46.56x
2021-02-09	51.97x
2021-02-08	50.68x
2021-02-05	55.35x
2021-02-04	50.61x
2021-02-03	49.69x
2021-02-02	49.55x
2021-02-01	40.41x
2021-01-29	39.21x
2021-01-28	40.01x
2021-01-27	41.83x
2021-01-26	43.38x
2021-01-25	43.70x
2021-01-22	42.43x
2021-01-21	41.71x
2021-01-20	40.64x
2021-01-19	42.05x
2021-01-15	41.80x
2021-01-14	41.37x
2021-01-13	44.47x
2021-01-12	44.49x
2021-01-11	44.06x
2021-01-08	44.01x
2021-01-07	44.35x
2021-01-06	43.91x
2021-01-05	39.78x
2021-01-04	39.06x
2020-12-31	36.00x
2020-12-30	37.04x
2020-12-29	39.35x
2020-12-28	40.15x
2020-12-24	40.58x
2020-12-23	40.97x
2020-12-22	41.97x
2020-12-21	40.63x
2020-12-18	40.71x
2020-12-17	43.24x
2020-12-16	44.28x
2020-12-15	46.32x
2020-12-14	43.99x
2020-12-11	42.67x
2020-12-10	43.77x
2020-12-09	41.99x
2020-12-08	44.40x
2020-12-07	43.58x
2020-12-04	45.32x
2020-12-03	45.42x
2020-12-02	45.83x
2020-12-01	48.38x
2020-11-30	44.16x
2020-11-27	53.46x
2020-11-25	47.99x
2020-11-24	47.41x
2020-11-23	46.42x
2020-11-20	46.03x
2020-11-19	43.91x
2020-11-18	42.05x
2020-11-17	46.63x
2020-11-16	42.02x
2020-11-13	39.47x
2020-11-12	41.09x
2020-11-11	40.29x
2020-11-10	4.60x
2020-11-09	4.06x
2020-11-06	3.72x
2020-11-05	4.08x
2020-11-04	3.74x
2020-11-03	3.48x
2020-11-02	3.37x
2020-10-30	3.60x
2020-10-29	3.56x
2020-10-28	3.19x
2020-10-27	3.88x
2020-10-26	4.16x
2020-10-23	4.70x
2020-10-22	4.34x
2020-10-21	4.23x
2020-10-20	4.21x
2020-10-19	4.95x
2020-10-16	5.25x
2020-10-15	4.94x
2020-10-14	4.59x
2020-10-13	5.08x
2020-10-12	5.26x
2020-10-09	4.98x
2020-10-08	4.60x
2020-10-07	4.99x
2020-10-06	3.76x
2020-10-05	3.51x
2020-10-02	2.83x
2020-10-01	2.72x
2020-09-30	4.13x
2020-09-29	4.68x
2020-09-28	4.07x
2020-09-25	3.56x
2020-09-24	4.01x
2020-09-23	3.83x
2020-09-22	4.57x
2020-09-21	4.76x
2020-09-18	6.95x
2020-09-17	6.65x
2020-09-16	6.57x
2020-09-15	5.83x
2020-09-14	6.58x
2020-09-11	5.94x
2020-09-10	5.94x
2020-09-09	5.27x
2020-09-08	4.92x
2020-09-04	4.45x
2020-09-03	4.97x
2020-09-02	5.07x
2020-09-01	5.33x
2020-08-31	5.40x
2020-08-28	5.83x
2020-08-27	5.02x
2020-08-26	5.10x
2020-08-25	5.05x
2020-08-24	5.04x
2020-08-21	5.41x
2020-08-20	5.52x
2020-08-19	5.12x
2020-08-18	5.14x
2020-08-17	5.20x
2020-08-14	5.00x
2020-08-13	5.07x
2020-08-12	4.96x
2020-08-11	32.71x
2020-08-10	32.85x
2020-08-07	31.88x
2020-08-06	30.80x
2020-08-05	29.27x
2020-08-04	29.00x
2020-08-03	28.93x
2020-07-31	28.27x
2020-07-30	29.32x
2020-07-29	29.69x
2020-07-28	29.80x
2020-07-27	29.97x
2020-07-24	29.32x
2020-07-23	31.74x
2020-07-22	31.35x
2020-07-21	33.89x
2020-07-20	33.78x
2020-07-17	30.16x
2020-07-16	29.93x
2020-07-15	26.93x
2020-07-14	27.30x
2020-07-13	27.44x
2020-07-10	30.91x
2020-07-09	31.74x
2020-07-08	32.91x
2020-07-07	33.48x
2020-07-06	36.01x
2020-07-02	37.04x
2020-07-01	36.71x
2020-06-30	41.15x
2020-06-29	45.09x
2020-06-26	40.11x
2020-06-25	39.22x
2020-06-24	38.29x
2020-06-23	37.02x
2020-06-22	34.89x
2020-06-19	34.90x
2020-06-18	32.98x
2020-06-17	32.06x
2020-06-16	30.73x
2020-06-15	31.64x
2020-06-12	27.65x
2020-06-11	27.48x
2020-06-10	28.25x
2020-06-09	26.45x
2020-06-08	28.14x
2020-06-05	26.81x
2020-06-04	28.37x
2020-06-03	25.47x

Related Metrics

EV/Sales P/E Ratio EBITDA All Metrics

EV/EBITDA Ratio: N/A

PLRX EV/EBITDA Ratio Chart

PLRX EV/EBITDA Ratio Metrics

PLRX Competitors' EV/EBITDA Ratio

EV/EBITDA Ratio Formula & Definition

PLRX EV/EBITDA Ratio History

Related Metrics